Laparoscopic retroperitoneal lymph node dissection

Journal of Endourology

Volumn 15, Issue 4, 2001, Pages 449-453

  Janetschek, Günter ^a   Peschel, Reinhard ^a   Hobisch, Alfred ^a   Bartsch, Georg ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER CONTROL; CANCER RECURRENCE; CANCER STAGING; CHYLOUS ASCITES; DIAGNOSTIC ACCURACY; FOLLOW UP; HUMAN; LAPAROSCOPIC SURGERY; LENGTH OF STAY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOCELE; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PARAAORTIC LYMPH NODE; PRIORITY JOURNAL; TESTIS TUMOR;

EID: 0035024292     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/089277901300189538     Document Type: Article

References (27)

1. Janetschek G, Hobisch A, Höltl L, Bartsch G. Retroperitoneal lymphadenectomy for clinical stage I nonseminomatous testicular tumor: laparoscopic versus open surgery and impact of learning curve. J Urol 1996;156:89.
2. Williams SD, Stablein DM, Einhorn LH, et al. Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathologic stage II testicular cancer. N Engl J Med 1987;317:1433.
3. Richie JP, Kantoff PW. Is adjuvant chemotherapy necessary for patients with stage B1 testicular cancer? J Clin Oncol 1991;9:1393.
4. Pizzocaro G, Nicolai N, Salvioni R. Evolution and controversies in the management of low-stage nonseminomatous germ-cell tumors of the testis. World J Urol 1994;12:113.
5. Donohue JP, Thornhill JA, Forster RS, Bihrle R, Rowland RG, Einhorn LH. The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer: The Indiana University experience (1965 to 1989). J Urol 1995;153:85.
6. Peckham MJ, Hendry WF. Clinical stage II nonseminomatous germ cell testicular tumors: Results of management by primary chemotherapy. Br J Urol 1985;57:763.
7. Logothetis CJ, Swanson DA, Dexeus F, et al. Primary chemotherapy for clinical stage II nonseminomatous germ cell tumor of the testis: A follow-up of 50 patients. J Clin Oncol 1987;5:96.
8. Socinski MA, Gernick, MB, Stomper PC, Fung CY, Richie JP. Stage II nonseminomatous germ cell tumors of the testis: An analysis of treatment options in patients with low volume retroperitoneal disease. J Urol 1988;140:1437.
9. Vugrin D, Whitmore WF, Sogani PC, Bains M, Herr HW, Golbey RB. Combined chemotherapy and surgery in treatment of advanced germ-cell tumors. Cancer 1981;47:2228.
10. Janetschek G, Hobisch A, Hittmair A, Höltl L, Peschel R, Bartsch G. Laparoscopic retroperitoneal lymphadenectomy after chemotherapy for stage II B nonseminomatous testicular carcinoma. J Urol 1999;161:477.
11. Weissbach L, Boedefeld EA for the Testis Tumor Study Group. Localization of solitary and multiple metastases in stage II nonseminomatous testis tumor as basis for a modified staging lymph node dissection in stage I. J Urol 1987;138:77.
12. Höltl L, Hobisch A, Knapp R, Moser N, Janetschek G, Bartsch G. Where are the primary landing sites for retroperitoneal metastases from testicular tumor? (abstract 1179). J Urol 1997;15:303.
13. Klima G, Janetschek G, Bartsch G. Fibrin sealant for uncontrollable hemorrhage during laparoscopy: The alternative to emergency laparotomy (abstract 1382). J Urol 1996;155:656.
14. Janetschek G, Hobisch A, Peschel R, Hittmair A, Bartsch G. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous testicular carcinoma. Long-term outcome. J Urol (in press).
15. Rassweiler JJ, Seemann O, Henkel TO, Stock C, Frede T, Alken F. Laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell tumors: Indications and limitations. J Urol 1996;156:1108.
16. Donohue JP, Foster RS, Rowland RG, Birhle R, Jones J, Geier G. Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation. J Urol 1990;144:287.
17. Donohue JP, Thornhill JA, Foster RS, Rowland RG, Bihrle R. Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): Modification of technique and impact on ejaculation. J Urol 1993;149:237.
18. Whitelaw GP, Smithwick RH. Some secondary effects of sympathectomy with particular reference to disturbance of sexual function. N Engl J Med 1951;245:212.
19. Richards KF, Risher KS, Flores JH, Christensen BJ: Laparoscopic Nissen fundoplication: Cost, morbidity, and outcome compared with open surgery. Surg Laparosc Endosc 1996;6:140.
20. Spirtos NM, Schlaerth JB, Gross GM, Spirtos TW, Sclaerth AC, Ballon SC. Cost and quality-of-life analyses of surgery for early endometrial cancer: Laparoscopy versus laparoscopy. Am J Obstet Gynecol 1996;174:1795.
21. Vilos GA, Alshimmiri MM. Cost-benefit analysis of laparoscopic versus laparotomy salpingo-oophorectomy for benign tubo-ovarian disease. J Am Assoc Gynecol Laparoscopists 1995;2:299.
22. Wenner J, Graffner H, Lindell G. A financial analysis of laparoscopic and open cholecystectoray. Surg Endosc 1995;9:702.
23. Bulletti C, Seracchioi R, Polli V, Ablonett A, Rossi S, Barbieri L, Callegaro A, Flamigni C. Financial impact in the Italian health service of laparoscopic versus laparotomic surgery for the treatment of ovarian cysts. Hum Reprod 1996;11:287.
24. Ingruber H, Bauer R, Salem G. Betriebs- und volkswirtschaftliche Auswirkungen von minimal-invasiven Behandlungsmethoden am Beispiel der endoskopischen Cholecystektomie in einem Krankenhaus der Schwerpunktversorgung. ÖKZ 1996;37:33.
25. Nicolai N, Pizzocaro G. A surveillance study of clinical stage I nonseminomatous germ cell tumors of the testis: 10-year followup. J Urol 1995;154:1045.
26. Böhlen D, Borner M, Sonntag RW, Fey MF, Studer UE. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors. J Urol 1999;161:1148.
27. Biebl W, Tönnemann J, Janetschek G, Höltl L, Kinzl J, Kemmler G, Bartsch G, Hobisch A. Quality of life after laparoscopic versus open retroperitoneal lymphadenectomy for testicular tumor: The patient's view (abstract 699). J Urol 1999;161:181.